Amundi
TXG icon

Amundi’s 10x Genomics TXG Stock Holding History

Amundi’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-204,847
Closed -$2.67M – 1684
2025
Q2 		$2.67M Sell
204,847
-115,493
-36% -$1.05M ﹤0.01% 1028
2025
Q1 		$2.55M Buy
320,340
+318,352
+16,014% +$4.01M ﹤0.01% 1091
2024
Q4 		$31.5K Sell
1,988
-98,904
-98% -$1.56M ﹤0.01% 1868
2024
Q3 		$2.03M Buy
100,892
+100,811
+124,458% +$2.08M ﹤0.01% 1153
2024
Q2 		$1.52K Sell
81
-62,044
-100% -$1.62M ﹤0.01% 1906
2024
Q1 		$1.8M Buy
62,125
+19,844
+47% +$872K ﹤0.01% 1188
2023
Q4 		$2.15M Buy
42,281
+7,514
+22% +$327K ﹤0.01% 1179
2023
Q3 		$1.34M Sell
34,767
-9,322
-21% -$485K ﹤0.01% 1256
2023
Q2 		$2.5M Sell
44,089
-28,178
-39% -$1.53M ﹤0.01% 1117
2023
Q1 		$3.71M Buy
72,267
+31,708
+78% +$1.48M ﹤0.01% 1049
2022
Q4 		$1.7M Buy
+40,559
New +$1.33M ﹤0.01% 1217
2022
Q3 		– Sell
-26,840
Closed -$1.16M – 1898
2022
Q2 		$1.16M Sell
26,840
-125,694
-82% -$6.52M ﹤0.01% 1140
2022
Q1 		$11.2M Sell
152,534
-32,839
-18% -$2.87M 0.01% 789
2021
Q4 		$19.4M Sell
185,373
-7,706
-4% -$1.18M 0.01% 687
2021
Q3 		$28.1M Buy
193,079
+1,110
+0.6% +$191K 0.02% 590
2021
Q2 		$37.6M Buy
+191,969
New +$34.7M 0.03% 514

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi's TXG Position: Q3 2025 in Review

Amundi sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 204,847 shares — an estimated $2.67M sold.

Amundi first reported a position in TXG in Q2 2021 and held it in 16 quarters. The position peaked at $37.6M in Q2 2021. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Amundi reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Amundi sold 204,847 10x Genomics shares in Q3 2025, an estimated $2.67M.
  • Amundi first reported a position in 10x Genomics in Q2 2021 and held it in 16 quarters.
  • Amundi's 10x Genomics position peaked at $37.6M in Q2 2021.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.